Meeting
2024 ASCO Quality Care Symposium
Adaptation of a modified Elixhauser comorbidity index to isolate the impact of body mass index on survival outcomes in patients with cancer in a large integrated healthcare system.
Authors
Matthew T. Newman
Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA
Matthew T. Newman , Zimin Zhuang , Robert Michael Cooper
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Survivorship
Sub Track
Cancer Outcome Disparities
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 124)
DOI
10.1200/OP.2024.20.10_suppl.124
Abstract #
124
Poster Bd #
C22
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival of patients with metastatic prostate cancer and comorbid obesity.
First Author: Nina Cheranda
Poster
2014 ASCO Annual Meeting
Endometrial cancer survivors: What is their knowledge about obesity?
First Author: Leslie Horn Clark
Poster
2014 ASCO Annual Meeting
Obesity and the odds of weight gain following androgen deprivation therapy for prostate cancer: Toward a risk adapted approach for ADT use.
First Author: Lior Zvi Braunstein
First Author: Ahmed Elkhanany